Bevacizumab for Advanced Breast Cancer: Hope, Hype, and Hundreds of Headlines-Reference-Cited by-同舟云学术

Bevacizumab for Advanced Breast Cancer: Hope, Hype, and Hundreds of Headlines

Published:2013-09-26 Issue:11 Volume:18 Page:1174-1179
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Fralick Michael¹,Ray Monali²,Fung Christina²,Booth Christopher M.³,Mallick Ranjeeta⁴,Clemons Mark J.⁵

Affiliation:

1. Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada;

2. Department of Medicine, University of Toronto, Toronto, Ontario, Canada;

3. Department of Oncology, Queen's University, Kingston, Ontario, Canada;

4. Ottawa Hospital Research Institute, Ottawa, Ontario, Canada;

5. Department of Medicine, The Ottawa Hospital Cancer Centre, University of Ottawa, Ottawa, Ontario, Canada

Abstract

Learning Objectives Summarize findings regarding the media's portrayal of bevacizumab with each phase of therapeutic development. Identify media sources of information about bevacizumab in each phase of therapeutic development.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://pericles-gcp.literatumonline.com/doi/pdf/10.1634/theoncologist.2013-0160

Reference25 articles.

1. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer;Miller;N Engl J Med,2007

2. RIBBON-1: Randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without Bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancer;Robert;J Clin Oncol,2011

3. Final overall survival (OS) results from the randomised, double-blind, placebo-controlled, phase III AVADO study of bevacizumab (BV) plus docetaxel (D) compared with placebo (PL) plus D for the first-line treatment of locally recurrent (LR) or metastatic breast cancer (mBC);Miles;Cancer Res,2009

4. Drugs in the news: An analysis of Canadian newspaper coverage of new prescription drugs;Cassels;CMAJ,2003

5. Reporting research in medical journals and newspapers;Entwistle;BMJ,1995

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Press Releases of Drug-Related Randomized Trial Results Prior to Publication in High-Impact Journals: an Observational Study;Journal of General Internal Medicine;2023-08-02

2. Media coverage of cancer therapeutics: A review of literature;Journal of Cancer Policy;2023-06

3. Biomolecular Prospecting, Informative Gaps, and the Cancer Clinic: A Qualitative Fieldwork and an Epistemological, Historical and Ethical Analysis of Informed Consent for Clinical Trials for Monoclonal Antibodies and Biobank Research;Frontiers in Genetics;2022-06-13

4. Strategies and Challenges in Clinical Trials Targeting Human Aging;The Journals of Gerontology Series A: Biological Sciences and Medical Sciences;2016-08-16

5. Cell-specific biomarkers and targeted biopharmaceuticals for breast cancer treatment;Cell Proliferation;2016-06-16